Dexamethasone in total joint replacements reduces pain, nausea and hospital stay duration .
Dexamethasone reduces length of hospitalization and improves postoperative pain and nausea after total joint arthroplasty: a prospective, randomized controlled trial
J Arthroplasty. 2013 Sep;28(8 Suppl):11-7130 patients who underwent total joint replacement of the knee or hip were enrolled in this study to determine the effects that different doses of dexamethasone can have on postoperative pain, nausea and functional and clinical outcomes. Patients were randomized into three separate treatment groups. The control group was administered ondansetron and the intervention groups received 1 or 2 doses of ondansetron and dexamethasone. The evidence of this study suggests that dexamethasone can reduce postoperative pain, nausea, length of hospital stay and required narcotics while increasing ambulation. A second dose of dexamethasone can further improve length of hospital stay, hydrocodone consumption, pain severity and rescue antiemetic medication requirements.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
